185 related articles for article (PubMed ID: 32390940)
21. Anaplastic thyroid cancer and hyperfractionated accelerated radiotherapy (HART) with and without surgery.
Jacobsen AB; Grøholt KK; Lorntzsen B; Osnes TA; Falk RS; Sigstad E
Eur Arch Otorhinolaryngol; 2017 Dec; 274(12):4203-4209. PubMed ID: 29019001
[TBL] [Abstract][Full Text] [Related]
22. Lenvatinib Administration for Anaplastic Thyroid Carcinoma with Brain Metastasis.
Obayashi A; Aoki K; Wada T; Furuie H; Kuraoka K; Hamamoto T; Tatsukawa T
Acta Med Okayama; 2023 Apr; 77(2):227-232. PubMed ID: 37094963
[TBL] [Abstract][Full Text] [Related]
23. Case Report: Successful Control of Pulmonary Metastatic Pheochromocytoma With Iodine-125 Seed Implantation.
Shi H; Wang C; Qiang W; Sun B; Wang H; Yuan Y; Hu W
Front Endocrinol (Lausanne); 2021; 12():714006. PubMed ID: 34434169
[TBL] [Abstract][Full Text] [Related]
24. [Anaplastic cancers of the thyroid. Is healing possible?].
Mellière D; Berrahal D; Becquemin JP; Lévy E; Lange F
Chirurgie; 1999 Feb; 124(1):52-7. PubMed ID: 10193032
[TBL] [Abstract][Full Text] [Related]
25. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Yin J; Foote RL; Kasperbauer JL; Rivera M; Asmus E; Garces NI; Janus JR; Liu M; Ma DJ; Moore EJ; Morris JC; Neben-Wittich M; Price DL; Price KA; Ryder M; Van Abel KM; Hilger C; Samb E; Bible KC
Thyroid; 2019 Nov; 29(11):1615-1622. PubMed ID: 31595822
[No Abstract] [Full Text] [Related]
26. Response to apatinib in chemotherapy-failed advanced spindle cell breast carcinoma.
Zhou N; Liu C; Hou H; Zhang C; Liu D; Wang G; Liu K; Zhu J; Lv H; Li T; Zhang X
Oncotarget; 2016 Nov; 7(44):72373-72379. PubMed ID: 27738308
[TBL] [Abstract][Full Text] [Related]
27. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Pacini F; Castagna MG; Brilli L; Pentheroudakis G;
Ann Oncol; 2012 Oct; 23 Suppl 7():vii110-9. PubMed ID: 22997443
[No Abstract] [Full Text] [Related]
28. Anaplastic thyroid cancer.
Ranganath R; Shah MA; Shah AR
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):387-91. PubMed ID: 26313900
[TBL] [Abstract][Full Text] [Related]
29. Reintroducing the Sodium-Iodide Symporter to Anaplastic Thyroid Carcinoma.
Schmohl KA; Dolp P; Schug C; Knoop K; Klutz K; Schwenk N; Bartenstein P; Nelson PJ; Ogris M; Wagner E; Spitzweg C
Thyroid; 2017 Dec; 27(12):1534-1543. PubMed ID: 29032724
[TBL] [Abstract][Full Text] [Related]
30. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
[TBL] [Abstract][Full Text] [Related]
31. Preoperative neoadjuvant targeted therapy with apatinib for inoperable differentiated thyroid cancer: A case report.
Zhang Y; Deng X; Ding Z; Kang J; Wu B; Guo B; Fan Y
Medicine (Baltimore); 2021 Mar; 100(12):e25191. PubMed ID: 33761701
[TBL] [Abstract][Full Text] [Related]
32. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
[TBL] [Abstract][Full Text] [Related]
33. [Short-term efficacy of ct-guided radioactive seed 125I implantation on residual or relapsing metastatic lymph nodes in advanced tumor patients after multi-modality treatment].
Jiang Y; Huang ZL; Wu PH; Zhang FJ; Zhao M; Huang JH; Fan WJ; Li CX; Gu YK; Zhang L; Gao F; Li W
Ai Zheng; 2008 Oct; 27(10):1082-7. PubMed ID: 18851789
[TBL] [Abstract][Full Text] [Related]
34. Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves survival in a murine model of anaplastic thyroid cancer.
Zhao B; Aggarwal A; Marshall JA; Barletta JA; Kijewski MF; Lorch JH; Nehs MA
Surgery; 2022 Jan; 171(1):227-234. PubMed ID: 34334212
[TBL] [Abstract][Full Text] [Related]
35. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in
Wang JR; Zafereo ME; Dadu R; Ferrarotto R; Busaidy NL; Lu C; Ahmed S; Gule-Monroe MK; Williams MD; Sturgis EM; Goepfert RP; Gross ND; Lai SY; Gunn GB; Phan J; Rosenthal DI; Fuller CD; Morrison WH; Iyer P; Cabanillas ME
Thyroid; 2019 Aug; 29(8):1036-1043. PubMed ID: 31319771
[No Abstract] [Full Text] [Related]
36. The coexistence of anaplastic and papillary carcinomas of the thyroid: a case presentation and literature review.
Fortson JK; Durden FL; Patel V; Darkeh A
Am Surg; 2004 Dec; 70(12):1116-9. PubMed ID: 15663057
[TBL] [Abstract][Full Text] [Related]
37. Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
Ursino S; Fiorica F; Stefanelli A; Pedriali M; Colosimo C; Cocuzza P; Mazzotti V; Taibi R; Cartei F; Greco C
Eur Rev Med Pharmacol Sci; 2014; 18(9):1368-72. PubMed ID: 24867515
[TBL] [Abstract][Full Text] [Related]
38. Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical Trial.
Xie L; Xu J; Sun X; Tang X; Yan T; Yang R; Guo W
Oncologist; 2019 Jul; 24(7):e542-e550. PubMed ID: 30559126
[TBL] [Abstract][Full Text] [Related]
39. Initial Therapy of Advanced Anaplastic Thyroid Cancer via Targeting VEGFR-2: A Case Report.
Cheng L; Jiao Q; Jin Y; Fu H; Zhang H; Chen L
Onco Targets Ther; 2019; 12():10495-10500. PubMed ID: 31819530
[TBL] [Abstract][Full Text] [Related]
40. Combining doxorubicin-nanobubbles and shockwaves for anaplastic thyroid cancer treatment: preclinical study in a xenograft mouse model.
Marano F; Frairia R; Rinella L; Argenziano M; Bussolati B; Grange C; Mastrocola R; Castellano I; Berta L; Cavalli R; Catalano MG
Endocr Relat Cancer; 2017 Jun; 24(6):275-286. PubMed ID: 28487350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
